Search

everythinglearnresearchcommunity

for

Search:↓

Conventional treatments like dutasteride and minoxidil are effective for male hair loss, with some alternative treatments also showing promise.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Nanotechnology offers promising new treatments for hair loss by improving targeted delivery and addressing key causes.

Direct-to-consumer teledermatology effectively treats male hair loss but may increase drug costs and requires monitoring for side effects.

Nanocarriers could improve hair loss treatments by delivering drugs directly to hair follicles.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Oral testosterone therapy raises heart risk more than other methods.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

Reduced neurosteroids and growth issues can harm fetal brain development, especially in males.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Muscles can make their own androgens, which may help muscle growth.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Bidens pilosa L. extract effectively treats androgen deficiency dry eye in rats.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Testosterone reduces knee flexibility by affecting relaxin receptors.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

Testosterone increases certain kidney protein levels, potentially raising blood pressure.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Diet changes hormone levels in pregnant ewes by affecting metabolism, not placental synthesis.